The Trump administration’s favored tactic to force companies to act
President Donald Trump is relying on drugmakers to lower U.S. prices on their own, but he might get less than he bargained for.
President Donald Trump is relying on drugmakers to lower U.S. prices on their own, but he might get less than he bargained for.
In a POLITICO Magazine opinion piece, leaders in Trump’s health department also caution the public to balance the risk and benefits of taking acetaminophen during pregnancy.
In a POLITICO Magazine opinion piece, leaders in Trump’s health department also caution the public to balance the risk and benefits of taking acetaminophen during pregnancy.
In a POLITICO Magazine opinion piece, leaders in Trump’s health department also caution the public to balance the risk and benefits of taking acetaminophen during pregnancy.
The administration is planning to take regulatory action to require companies to include more drug information
The administration is planning to take regulatory action to require companies to include more drug information
The administration is planning to take regulatory action to require companies to include more drug information
The administration is planning to take regulatory action to require companies to include more drug information
The administration is planning to take regulatory action to require companies to include more drug information
The administration is planning to take regulatory action to require companies to include more drug information
The administration is planning to take regulatory action to require companies to include more drug information
The decision could make it difficult for young healthy children to get a Covid-19 shot.
The decision could make it difficult for young healthy children to get a Covid-19 shot.
Vinay Prasad had been dismissed less than two weeks ago.
Vinay Prasad had been dismissed less than two weeks ago.
The move ends investments in projects involving mRNA technology.
The move ends investments in projects involving mRNA technology.
The move ends investments in projects involving mRNA technology.
The move ends investments in projects involving mRNA technology.
The Trump administration projects as many as 1.8 million people, including many DACA recipients, could lose coverage.
The Trump administration projects as many as 1.8 million people, including many DACA recipients, could lose coverage.
The Trump administration projects as many as 1.8 million people, including many DACA recipients, could lose coverage.
The Trump administration projects as many as 1.8 million people, including many DACA recipients, could lose coverage.
The Trump administration projects as many as 1.8 million people, including many DACA recipients, could lose coverage.
The push will likely draw lawsuits from the pharmaceutical industry.
The push will likely draw lawsuits from the pharmaceutical industry.
The withdrawal comes after questions were raised about her academic credentials.
The withdrawal comes after questions were raised about her academic credentials.
Drug and medical device makers didn’t oppose Robert F. Kennedy Jr.’s confirmation as health secretary but are speaking up in opposition to the agency downsizing he ordered.
The agency denied Triton Distribution’s application to sell flavored e-liquids.